Connect with us

Business Wire

TransPerfect Life Sciences Takes Center Stage at DIA 2019 with a Theatrical Stakeholder Collaboration Workshop

Business Wire

Published

on

Reading Time: 3 minutes

E-Clinical Leader to Demo Latest Innovations in Practical Study
Management Solutions

NEW YORK & SAN DIEGO–(BUSINESS WIRE)–TransPerfect
Life Sciences
, a leading provider of services and technologies to
support global product development for the life sciences industry, today
announced highlights of its upcoming presence at DIA
2019
, including a workshop entitled “Setting the Stage for Effective
Stakeholder Collaboration,” as well as live demos of the award-winning
Trial Interactive e-clinical platform.

The
workshop
will be held on June 26 at 4:15 PM and will be led by
Christine Morris, Executive Director of TransPerfect Life Sciences
Solutions. Rather than delivering a typical conference presentation,
Morris is taking a novel and artistic approach to the session. Talent
from North Carolina’s Cary Playwrights’ Forum will assist Morris with
stage adaptations of real-world clinical research scenarios, guiding
attendees through empathy-mapping exercises and providing practical and
powerful tools for stakeholder management.

In addition, TransPerfect will preview
new e-clinical innovations
in its Trial Interactive platform—the
cloud-based solution designed by clinical professionals for clinical
professionals. Join TransPerfect Life Sciences Head of Product
Development, Jay Smith, at Booth #1838 on June 24 at 1:30 PM for an
e-clinical innovation talk entitled “Mobile, Machine Learning, and More:
Simplifying Clinical Processes.” The Trial Interactive innovation team
will be on hand to demo solutions that enable clinical teams to stay
inspection ready while reducing administrative costs and speeding
timelines.

TransPerfect President and CEO Phil Shawe stated, “Centralizing the full
clinical document lifecycle and maintaining inspection readiness are
priorities for us. Our focus is on maximizing collaboration and
simplifying workflows for study teams and utilizing best-practice
technology to help improve and streamline trials. I’d also like to thank
the North Carolina-based actors who will help facilitate Christine’s
workshop. They are sure to be an engaging addition to DIA 2019.”

New Developments on Display at Booth #1838:

Trial Interactive 10.0 This upcoming release introduces
an improved user experience with nuanced, practical features developed
over 10+ years of e-clinical innovation. Faster and more intuitive,
version 10.0 includes several new enhancements that ensure Trial
Interactive continues to be a top choice of users seeking a practical
and time-saving e-clinical platform.

myTI – Trial Interactive’s mobile eTMF solution simplifies
workflows for CRAs with mobile document capture, real-time document work
streams, and insights into completeness—anytime and anywhere. During DIA
2019, attendees can stop by to experience the advantages of mobile
e-clinical solutions by participating in a brief myTI-powered scavenger
hunt and entering for a chance to win a TMF Inspection-Readiness
Workshop or a $100 American Express gift card.

TI GlobalLearn – TransPerfect’s compliance-focused learning
management system (LMS) enables the training and certification of study
teams on study protocol, regulatory, and SOP compliance. Since
GlobalLearn’s release, study teams have experienced the importance of a
compliance-focused LMS for training study personnel, enjoying the
benefits of expedited training timelines, reduced compliance risks, and
growth in overall operational excellence.

TI Collaborate – Trial Interactive’s content management solution
provides online collaborative and controlled document authoring,
approval, and content management-related training (via integration with
TI GlobalLearn). With 21 CFR Part 11 compliant workflows and approvals,
the solution offers an end-to-end service platform for clinical content
management, including direct integrations with TI eTMF. Study teams are
rapidly adopting Trial Interactive’s clinical content management
solution to streamline document processes.

Trial Interactive is consistently praised by clinical professionals as
the most practical, user-friendly e-clinical platform, featuring
powerful solutions that accelerate site activation while reducing study
timelines, costs, compliance risks, and administrative burdens. Contact info@trialinteractive.com
for more information.

About TransPerfect Trial Interactive

TransPerfect’s Trial
Interactive
solution provides a collaborative web-based platform for
study start-up and eTMF that enables sponsors, CROs, IRBs, central
laboratories, and other vendors to maintain and update clinical trial
documentation in a secure online environment. With fully searchable
solutions, including investigator portals, Trial Interactive streamlines
study timelines and reduces the administrative burdens of global
clinical trials. As part of TransPerfect’s Life Sciences division, Trial
Interactive is dedicated to working with clients on a global,
collaborative level, supporting a wide range of requirements including
e-feasibility, eTMF review/reconciliation, pharmacovigilance and safety
management, endpoint adjudication, and product licensing and alliance
management. For more information on Trial Interactive, please contact info@trialinteractive.com
or +1 212.400.8848, or visit www.trialinteractive.com.

About TransPerfect

TransPerfect
is the world’s largest provider of language
and technology
solutions
 for global business. From offices in over 90 cities on six
continents, TransPerfect offers a full range of services in 170+
languages to clients worldwide. More than 5,000 global organizations
employ TransPerfect’s GlobalLink® Product
Suite to simplify management of multilingual content. With an
unparalleled commitment to quality and client service, TransPerfect is
fully ISO
9001
 and ISO
17100
 certified. TransPerfect has global headquarters in New York,
with regional headquarters in London and Hong Kong. For more
information, please visit our website at www.transperfect.com.

Contacts

Ryan Simper +1 212.689.5555
mediainquiry@transperfect.com

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.

Business Wire

Bin Zayed Group’s global oil chain and BBOSS reached a strategic cooperation

Business Wire

Published

on

Reading Time: 2 minutes

NEW YORK–(BUSINESS WIRE)–Recently, Top investment master in the world, Prince of Abu Dhabi, Chairman of the Board of Directors of the Bin Zayed Group, His Excellency Sheikh Khaled Bing Zayed Al Nahyan, Chairman of the Board of Directors of the Abu Dhabi Sovereign Fund, chaired the “Global refueling chain OPC Strategic Cooperation Seminar” in Bangkok, Thailand. The Bin Zayed Group, a partner from 50 countries around the world, held a one-day strategic discussion on the use of the BBOSS accounting tool to launch the global refueling chain. Finally reached a consensus that the OPC global refueling system uses the BBOSS accounting tool as a third-party tool for OPC points.

Liu Shijiang, secretary general of the China Aviation Rescue Alliance, attended the seminar and reached a strategic cooperation intention on the cooperation between the Air Rescue Association and OPC.

(BIN ZAYED GROUP, (BZG),) is a global oil, energy, bank, finance, real estate, top hotel, antique and cultural relics investment enterprise founded by Prince Sheikh Khaled Bin Zayed Al Nahyan. Its “Abu Dhabi sovereign fund”, with a size of $1.3 trillion (10 trillion yuan), once ranked first in the world and now ranks second in the world.

The global refueling chain project launched by the Bin Zayed Group is the first subdivided market project based on block chain technology to solve the problem of gas stations. This project not only solves the problem of expensive refueling, The problem of the number of passengers at gas stations is due to the use of the BBOSS points tool to give all participants more benefits. The global network of global refueling chain projects will make full use of the BBOSS accounting tool, meaning that the physical application of BBOSS tools is rapidly expanding to more areas around the world.

The cooperation with the China Aviation Rescue Alliance also applies the oil chain to people’s livelihood, refueling BBOSS Token to let more consumers feel the convenience and benefits of BBOSS accounting tools to their lives.

Contacts

Jan Liu

Jan@globalnews.com

Continue Reading

Business Wire

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Textron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire

Published

on

Reading Time: 2 minutes

LOS ANGELES–(BUSINESS WIRE)–$TXT #TXTThe Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Textron Inc. (“Textron” or “the Company”) (NYSE: TXT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between January 31, 2018 and October 17, 2018, inclusive (the ”Class Period”), are encouraged to contact the firm before October 21, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Textron suffered from slowing end-market sales of Arctic Cat products, leaving the sales channel filled with excess inventory. The Company provided significant discounts in an effort to clear the aging inventory, which impacted its earnings. Based on these facts, the Company’s public statements were false and materially misleading. When the market learned the truth about Textron, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contacts

The Schall Law Firm

Brian Schall, Esq.

www.schallfirm.com

Office: 310-301-3335

Cell: 424-303-1964

info@schallfirm.com

Continue Reading

Business Wire

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Textron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire

Published

on

Reading Time: 2 minutes

LOS ANGELES–(BUSINESS WIRE)–$TXT #TXTThe Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Textron Inc. (“Textron” or “the Company”) (NYSE: TXT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between January 31, 2018 and October 17, 2018, inclusive (the ”Class Period”), are encouraged to contact the firm before October 21, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Textron suffered from slowing end-market sales of Arctic Cat products, leaving the sales channel filled with excess inventory. The Company provided significant discounts in an effort to clear the aging inventory, which impacted its earnings. Based on these facts, the Company’s public statements were false and materially misleading. When the market learned the truth about Textron, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contacts

The Schall Law Firm

Brian Schall, Esq.

www.schallfirm.com

Office: 310-301-3335

Cell: 424-303-1964

info@schallfirm.com

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets

Trending

Please turn AdBlock off